Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Verona Pharma Plc ADR (NASDAQ: VRNA) closed the day trading at $66.09 up 4.00% from the previous closing price of $63.55. In other words, the price has increased by $4.00 from its previous closing price. On the day, 0.89 million shares were traded. VRNA stock price reached its highest trading level at $66.4199 during the session, while it also had its lowest trading level at $63.0.
Ratios:
For a better understanding of VRNA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.48 and its Current Ratio is at 10.63. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $68.
On October 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Rickard Kathleen A. sold 79,264 shares for $8.35 per share. The transaction valued at 661,942 led to the insider holds 2,608,976 shares of the business.
KATHLEEN RICKARD bought 9,908 shares of VRNA for $621,232 on Mar 12 ’25. On Dec 05 ’24, another insider, ZACCARDELLI DAVID, who serves as the President and CEO of the company, sold 640,264 shares for $5.01 each. As a result, the insider received 3,205,226 and left with 14,367,552 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRNA now has a Market Capitalization of 8406647296 and an Enterprise Value of 44759085056. For the stock, the TTM Price-to-Sale (P/S) ratio is 133.17 while its Price-to-Book (P/B) ratio in mrq is 27.34. Its current Enterprise Value per Revenue stands at 1058.66 whereas that against EBITDA is -298.456.
Stock Price History:
The Beta on a monthly basis for VRNA is 0.16, which has changed by 3.1435738 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, VRNA has reached a high of $70.40, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 11.14%, while the 200-Day Moving Average is calculated to be 80.40%.
Shares Statistics:
Over the past 3-months, VRNA traded about 1.43M shares per day on average, while over the past 10 days, VRNA traded about 1370730 shares per day. A total of 84.63M shares are outstanding, with a floating share count of 74.21M. Insiders hold about 12.31% of the company’s shares, while institutions hold 69.57% stake in the company. Shares short for VRNA as of 1740700800 were 9002361 with a Short Ratio of 6.30, compared to 1738281600 on 8286846. Therefore, it implies a Short% of Shares Outstanding of 9002361 and a Short% of Float of 11.04.
